MD Anderson Madrid Gynecology Department is accredited as a European Training Center by the ESGO Published on 06/02/2023 The specialized center is the first private hospital to obtain such recognition in Europe
The individualization of surgical management and targeted medical treatment - keys to improving survival rates and achieving a good quality of life for women with gynecologic cancer Published on 18/05/2022 During the congress, experts in gynecologic cancer from Europe and the United States will share their knowledge and the latest news on each type of tumor will be discussed
Patients with advanced ovarian cancer and a BRCA mutation achieve disease-free intervals of about 5 years thanks to treatment with PARP inhibitors Published on 06/05/2021 PARP inhibitors are a series of drugs that intervene in the repair of genetic damage, and it has been shown that, after surgery or chemotherapy, they achieve high remission rates in advanced ovarian cancer with disease-free survival rate of up to 56 months compared to the 13 months previously achieved.
MD Anderson Cancer Center Madrid postpones the International Meeting in Gynecologic Oncology Published on 05/03/2020 This decision is accordance with the guidelines published by of the Ministry of Health, the Ministry of Health of the Autonomous Regions and the Medical Society.